Journal of

Hypertension and ManagementISSN: 2474-3690

Archive

 Open Access DOI:10.23937/2474-3690/1510043

White Coat Hypertension in Children and Adolescents: Innocent or Not?

Evrim Kargin Cakici, Eda Didem Kurt Sukur, Fatma YazilitaƟ, Gokce Gur, Tulin Gungor, Evra Celikkaya, Deniz Karakaya and Mehmet Bulbul

Article Type: Research Article | First Published: September 30, 2019

The clinical significance of white coat hypertension is still uncertain. We aimed to evaluate children with white coat hypertension regarding their clinical, laboratory characteristics, evidence of target organ damage and compare them to normotensive and hypertensive children. Fourty patients diagnosed with white coat hypertension, 40 patients with primary hypertension and 40 normotensive children of similar age, gender and body mass index were included in the study. Ambulatory blood pressure mo...

 Open Access DOI:10.23937/2474-3690/1510042

Neutrophil to Lymphocyte Ratio as a Predictor of Left Ventricular Hypertrophy in Patients with Newly Diagnosed Hypertension

Abdulmecit Afsin, Ramazan Asoglu, Ertugrul Kurtoglu and Hakan Kaya

Article Type: Original Article | First Published: August 05, 2019

Concentric or eccentric left ventricular hypertrophy (LVH) is an independent prognostic factor of major cardiovascular events in hypertension (HT). A high neutrophil to lymphocyte ratio (NLR) is correlated with high mortality and poor prognosis in cardiovascular disease. This study was performed to investigate the associations between NLR and different left ventricular (LV) geometric patterns in patients with newly diagnosed HT....

 Open Access DOI:10.23937/2474-3690/1510041

New Pharmacologic Therapy for Hypertension in Pregnancy

Byrne TJ

Article Type: Review Article | First Published: July 03, 2019

There has been virtually no change for three decades in the treatment of hypertension in pregnancy and it's many namesakes: Pre-eclampsia, gestational hypertension, superimposed preeclampsia, gestosis, etc. all of which shall be referred to in the rest of this article as PIH. In part this is because of an incomplete understanding of its physiology and pathophysiology, partly because the only widely accepted treatment, labetalol, does not work well and causes fetal growth restriction. This is a s...

Volume 5
Issue 2